Tag Archive: EU

Objection to Monsanto’s application for commodity clearance for MON 89034 x MON 88017

This submission by Monsanto makes a joke of biosafety risk assessment in that it is not based on the actual event under consideration, but rather, the applicant posits claim of lack of harm, toxicity, and allergenicity based on data carried out on other lines containing the same transgene/event. This violates the case by case approach to GMO risk assessment enshrined in the GMO Act 1997. It also lacks sufficient scientific data to support claims of safety and this is exacerbated by lack of peer reviewed information on this event. In addition, the applicant has not considered the health impacts of the herbicide to which this event is engineered to tolerate. Furthermore, approval of this commodity import is likely to significantly impact upon commercial and emerging maize producers, and could have further impacts along the value chain. There are other issues affecting animal feed producers and consumers (the continuation of cheap chicken imports from the EU, for example), the resolution of which would do more to strengthen South Africa?s agricultural sector. It is the opinion of the ACB that this application should be rejected on both biosafety and socio-economic grounds.

read more

BT-Maize MON863 and MON863 X MON810 / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)
  • Objections to the Application Made by Monsanto South Africa for a Commodity Import Permit of Grain for Feed and Food Purposes that may Contain Maize Grains Derived From Insect-Protected Maize Line Mon863 and Maize Hybrids Mon863 X Mon810
    Mariam Mayet and Shenaz Moola, August 2004
read more
  • CoverLetter_Mon830X810.pdf Cover Letter to the Registrar
    August 2004
read more
OVERVIEW
SCIENTIFIC OBJECTIONS

A scientific assessment was made of the available information. The main findings of this assessment, which are discussed in greater detail later in the document, are:

  • A full assessment of the scientific data could not be made because of the designation of large sections of this data as Confidential Business Information
  • The molecular characterisation information provided by the notifier indicates several irregularities including open reading frames, a missing stop codon and truncated constructs which could give rise to unintended gene effects
  • There is evidence of structural instability arising out of the use of the 35S CaMV promoter and there is a call for the discontinuation of the use of this genetic element in the development of transgenic plants
  • The protocols for assessing gene expression in transgenic plants are